TAUNS Laboratories, Inc. (197A.T) stock price, financials & research

Regular session · JST · Market data may be delayed.

Company profile

TAUNS Laboratories, Inc. is a company dedicated to the creation and production of in-vitro diagnostic pharmaceuticals and various types of measuring equipment. Additionally, the firm facilitates the international trade (import and export) of an extensive selection of instruments, covering industrial, medical, physical, and chemical measurement applications. Founded in April 1987, the company maintains its principal office in Izunokuni, Japan.

Industry: Medical - Specialties
Sector: Healthcare
Headquarters: JP
CEO: Masaki Nonaka
Listed since: Jun 20, 2024
Employees: 271

Market position

Day range

Current ¥506

¥505¥510

52-week range

Current ¥506

¥463¥594

Open: ¥510
Previous close: ¥510
Volume: 41.3K; 0.14× average
Average volume: 303.63K; Average daily volume
Market cap: 53.87B JPY
Beta: 0.73; Market reference 1
50-day average: ¥478.58; +5.73% above average
200-day average: ¥507.07; -0.21% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 67.31B JPY
P/E (TTM): 9.66×
P/B (TTM): 2.75×
P/S (TTM): 3.75×
EV / EBITDA: 12.64×
Earnings yield: 11.08%
Free cash flow yield: -13.33%
Dividend yield: 5.53%

Profitability & efficiency

Gross margin: 61.39%
Operating margin: 29.23%
Net margin: 38.24%
Return on equity: 28.30%
Return on assets: 12.32%
Return on invested capital: 6.86%

Financial health

Debt / equity: 1.09×
Current ratio: 1.26×
Altman Z-score: 2.53
Piotroski F-score: 4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

14.37B JPY-22.86%

Operating income

4.2B JPY-49.18%

Net income

5.5B JPY-12.99%

Metric (JPY)	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	14.37B JPY	18.63B JPY	18.43B JPY	15.67B JPY	17.46B JPY
Cost of goods sold	6.15B JPY	6.3B JPY	5.94B JPY	6.89B JPY	3.17B JPY
Gross profit	8.22B JPY	12.33B JPY	12.5B JPY	8.79B JPY	14.29B JPY
Research and development	—	1.13B JPY	—	723.37M JPY	776.31M JPY
Selling, general, and administrative	4.02B JPY	4.06B JPY	3.04B JPY	3.82B JPY	2.32B JPY
Operating expenses	4.02B JPY	4.06B JPY	4.47B JPY	3.82B JPY	3.1B JPY
Interest income	16.69M JPY	7.04M JPY	2.34M JPY	3.97M JPY	35K JPY
Interest expense	264.04M JPY	102.9M JPY	31.21M JPY	21.81M JPY	8.38M JPY
Depreciation and amortization	1.13B JPY	715.43M JPY	676.16M JPY	639.97M JPY	567.24M JPY
Operating income	4.2B JPY	8.27B JPY	8.03B JPY	4.97B JPY	11.19B JPY
Net income	5.5B JPY	6.32B JPY	5.77B JPY	3.03B JPY	4.48B JPY

Company facts updated Aug 25, 2026.

Earnings

Latest EPS result: 28.92

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Estimates unavailable

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥36.00

2025 complete year+29.7% since 2024

2026 partial: ¥14.00

¥27.75

2,024

¥36.00

2,025

¥14.00

2,026*

* Partial calendar year in the available dividend history.

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
DividendUpcoming	Jun 29, 2027	¥14.50Semi-Annual	Jun 30, 2027	Jun 29, 2027
Dividend	Jun 29, 2026	¥14.00Semi-Annual	Dec 31, 2026	Dec 29, 2026
Dividend	Dec 29, 2025	¥14.00Annual	Dec 31, 2025	Mar 13, 2026
Dividend	Jun 27, 2025	¥22.00Special	Jun 30, 2025	Sep 29, 2025
Dividend	Dec 27, 2024	¥6.00Annual	Dec 31, 2024	Mar 13, 2025
Dividend	Jun 27, 2024	¥21.75Special	Jun 30, 2024	Sep 27, 2024